MNBio., I now recall the study Cards is referring to. The study set out to see the differences in CVD events I believe was the end point, between patients who were stented verses those who were medicated not stented. The study followed a large population so it was well powered. The results: people who were medicated did stat sig better than those who were stented. The study showed that stenting was often unnecessary and done far too often. Money comes to mind.
My point is since the compound is different from Vascepa they would need to run a CVOT. Otherwise they can just treat triglycerides, which is fine. We know that all fish oil CVOT trials have failed except RI trial.
News 
Market Data 
Discover 
